Virtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching [PDF]
We recently introduced Drug Profile Matching (DPM), a novel virtual affinity fingerprinting bioactivity prediction method. DPM is based on the docking profiles of ca.
Czobor, P. +6 more
core +1 more source
Introduction Volumes of hippocampus and cholinergic basal forebrain are associated with delayed recall performance and may modulate the effect of a muscarinic receptor antagonist on delayed recall in healthy volunteers. Methods We studied 15 older adults
Stefan J. Teipel +4 more
doaj +1 more source
Neuronal localization of m1 muscarinic receptor immunoreactivity in the monkey basolateral amygdala. [PDF]
McDonald AJ, Mott DD.
europepmc +1 more source
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor [PDF]
Background: Selective and potent positive allosteric modulators (PAMs) of the M1 mAChR have been recently described. Results: Use of structural analogues and mutagenic mapping identified the mechanistic basis for increased PAM activity.
Abdul-Ridha +42 more
core +2 more sources
Bruno A, Alessi M, Soresi S, et al. J Inflamm Res. 2011;4:51–59. The Editor and Publisher of Journal of Inflammation Research wish to retract the published article.
Bruno A +8 more
doaj
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. [PDF]
Scarpa M +14 more
europepmc +1 more source
The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes. [PDF]
Marsango S +10 more
europepmc +1 more source
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. [PDF]
Dwomoh L +13 more
europepmc +1 more source
D₂ Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways [PDF]
Regulator of G-protein signaling 9-2 (RGS9-2), a member of the RGS family of Gα GTPase accelerating proteins, is expressed specifically in the striatum, which participates in antipsychotic-induced tardive dyskinesia and in levodopa-induced dyskinesia. We
Axelrod, Jeffrey D. +10 more
core
M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways [PDF]
Corinne Leloup +5 more
openalex +1 more source

